Buhloncology
Buhloncology develops anticancer drugs and provides strategic and operational leadership.
Buhloncology is active in the biotechnology, medical, oncology, pharmaceutical space based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2010.
The company sits in the biotechnology, medical, oncology, pharmaceutical segment, where it competes on its core product or service.
The company is recorded as being based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
The company is listed at the Private company stage of development.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology, Medical, Oncology, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2010 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: buhloncology.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account